1.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37606512
RESUMEN
Among 43 pregnant women receiving multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment with bedaquiline and/or delamanid, 98% had favorable treatment outcomes. Of 31 continued pregnancies, 81% had live births with no reported malformations, and 68% of neonates had normal birth weights. Effective MDR/RR-TB treatment during pregnancy can improve maternal outcomes without harming neonates.